Gina
Gina was diagnosed with MS in 1994. She’s recently switched from Gilenya® (fingolimod) capsules to TASCENSO ODT.
Read Gina’s story
Taia
Taia was diagnosed with MS in 2023 when she was 24 years old. TASCENSO ODT is her first disease modifying treatment for MS and she describes the experience as a breeze.
Read Taia’s story
Diane
Diane was diagnosed with MS in 2001. She switched to TASCENSO ODT to avoid potential inconsistencies associated with generic fingolimod capsules.
Read Diane’s story
A friendly, familiar team is waiting here at Cycle Vita, for you and your patients, at every step.
A friendly, familiar team is waiting here at Cycle Vita, for you and your patients, at every step.
+1 (888) 360-8482
Gilenya® is a registered trademark of Novartis AG.